Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vibeke Strand

Showing results (121-130 of 435) with videos related to

Pageof 44
Sort By:
The Lancet. Rheumatology|January 22, 2024
The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trialVibeke Strand, David R W Jayne, Audra Horomanski, et al.
Annals of the Rheumatic Diseases|May 31, 2011
Validation of pain and patient global scales in chronic gout: data from two randomised controlled trialsJasvinder A Singh, Shuo Yang, Vibeke Strand, et al.
Rheumatology (Oxford, England)|April 28, 2009
Evaluation of composite measures of treatment response without acute-phase reactants in patients with rheumatoid arthritisJeffrey D Greenberg, Leslie R Harrold, Mary J Bentley, et al.
Health and Quality of Life Outcomes|May 14, 2013
Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled studyVibeke Strand, David Fiorentino, ChiaChi Hu, et al.
Arthritis Research & Therapy|May 23, 2016
Discordance between patient and physician assessments of global disease activity in rheumatoid arthritis and association with work productivityJosef S Smolen, Vibeke Strand, Andrew S Koenig, et al.
Rheumatology (Oxford, England)|December 29, 2016
Analysis of haematological changes in tofacitinib-treated patients with rheumatoid arthritis across phase 3 and long-term extension studiesHendrik Schulze-Koops, Vibeke Strand, Chudy Nduaka, et al.
Rheumatology and Therapy|September 12, 2018
Local Effects Following Single and Repeat Intra-Articular Injections of Triamcinolone Acetonide Extended-Release: Results from Three Nonclinical Toxicity Studies in DogsNeil Bodick, Toni Williamson, Vibeke Strand, et al.
Arthritis Care & Research|August 27, 2016
Tofacitinib in Combination With Conventional Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis: Patient-Reported Outcomes From a Phase III Randomized Controlled TrialVibeke Strand, Joel M Kremer, David Gruben, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 5, 2016
Reanalysis of the Multi-Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic-Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et alJeffrey R Curtis, Grace C Wright, Vibeke Strand, et al.
Lupus Science & Medicine|November 15, 2014
Clinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimumab trialsRichard Furie, Michelle A Petri, Vibeke Strand, et al.
Pageof 44

Showing results (121-130 of 435) with videos related to

Sort By:
Pageof 44
The Lancet. Rheumatology|January 22, 2024
The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trialVibeke Strand, David R W Jayne, Audra Horomanski, et al.
Annals of the Rheumatic Diseases|May 31, 2011
Validation of pain and patient global scales in chronic gout: data from two randomised controlled trialsJasvinder A Singh, Shuo Yang, Vibeke Strand, et al.
Rheumatology (Oxford, England)|April 28, 2009
Evaluation of composite measures of treatment response without acute-phase reactants in patients with rheumatoid arthritisJeffrey D Greenberg, Leslie R Harrold, Mary J Bentley, et al.
Health and Quality of Life Outcomes|May 14, 2013
Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled studyVibeke Strand, David Fiorentino, ChiaChi Hu, et al.
Arthritis Research & Therapy|May 23, 2016
Discordance between patient and physician assessments of global disease activity in rheumatoid arthritis and association with work productivityJosef S Smolen, Vibeke Strand, Andrew S Koenig, et al.
Rheumatology (Oxford, England)|December 29, 2016
Analysis of haematological changes in tofacitinib-treated patients with rheumatoid arthritis across phase 3 and long-term extension studiesHendrik Schulze-Koops, Vibeke Strand, Chudy Nduaka, et al.
Rheumatology and Therapy|September 12, 2018
Local Effects Following Single and Repeat Intra-Articular Injections of Triamcinolone Acetonide Extended-Release: Results from Three Nonclinical Toxicity Studies in DogsNeil Bodick, Toni Williamson, Vibeke Strand, et al.
Arthritis Care & Research|August 27, 2016
Tofacitinib in Combination With Conventional Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis: Patient-Reported Outcomes From a Phase III Randomized Controlled TrialVibeke Strand, Joel M Kremer, David Gruben, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 5, 2016
Reanalysis of the Multi-Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic-Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et alJeffrey R Curtis, Grace C Wright, Vibeke Strand, et al.
Lupus Science & Medicine|November 15, 2014
Clinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimumab trialsRichard Furie, Michelle A Petri, Vibeke Strand, et al.
Pageof 44